Delving into the Latest Updates on Beijing Jiuneng Tianyuan Technology Co., Ltd. with Synapse

Overview

主要目的：以北京九能天远科技有限公司生产的尼麦角林片（规格：10 mg）为受试制剂，按生物等效性试验的有关规定，与Pfizer Italia S.r.l./Upjohn EESV持证的尼麦角林片（规格：10 mg，商品名：Sermion®，参比制剂）对比在健康人体内的相对生物利用度，考察两制剂的人体生物等效性。次要目的：观察尼麦角林片受试制剂和参比制剂（商品名：Sermion®）在健康受试者中的安全性。

[Translation]

Primary objective: To compare the relative bioavailability of Nicergoline Tablets (specification: 10 mg) produced by Beijing Jiuneng Tianyuan Technology Co., Ltd. with Nicergoline Tablets (specification: 10 mg, trade name: Sermion®, reference preparation) certified by Pfizer Italia S.r.l./Upjohn EESV in healthy human bodies, and investigate the bioequivalence of the two preparations. Secondary objective: To observe the safety of Nicergoline Tablets test preparation and reference preparation (trade name: Sermion®) in healthy subjects.

Start Date26 Nov 2022

Sponsor / Collaborator

Beijing Jiuneng Tianyuan Technology Co., Ltd.

100 Clinical Results associated with Beijing Jiuneng Tianyuan Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Jiuneng Tianyuan Technology Co., Ltd.

Login to view more data

100 Deals associated with Beijing Jiuneng Tianyuan Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Jiuneng Tianyuan Technology Co., Ltd.

Login to view more data